XELOX for Metastatic Breast Cancer

NCT00204776 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Capecitabine and Oxaliplatin

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]